跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 243 条关于
“TPDs”
全部
243
临床试验
180
药物
27
机构
1
资讯
35
5个月前
NJ Bio and Ajinomoto Bio-Pharma Services Partner to Advance Antibody-Drug Conjugate Development Through AJICAP™ Platform Integration
8个月前
Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Advance Degrader-Antibody Conjugate Platform
去年
MHRA Approves Joenja (leniolisib) as First Treatment for Rare Immune Disease APDS
去年
PDS Biotech's VERSATILE-003 Phase 3 Trial for HPV16-Positive Head and Neck Cancer to Start Q1 2025
去年
PDS Biotech Updates Phase 3 VERSATILE-003 Trial Design for HPV16-Positive HNSCC
去年
First European Patient Receives Breakthrough Treatment for Ultra-Rare APDS Immune Disorder
11个月前
FDA Grants Priority Review for Leniolisib in Children with Rare Immunodeficiency APDS
去年
Pharming's Leniolisib Shows Positive Phase 3 Data in Young Children with APDS
2年前
PDS Biotech's Versamune® HPV Plus Pembrolizumab Shows Promising Results in HPV16-Positive Head and Neck Cancer
去年
PDS Biotechnology Secures $11 Million in Latest Funding Round
第 1 页,共 4 页
上一页
下一页